Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical compositions comprising N-(3,5-dimethoxyphenyl)-N′-(1-methylethyl)-N-[3-(1-methyl-1H-pyrazol-4-yl)quinoxalin-6-yl]ethane-1,2-diamine

Pharmaceutical compositions comprising N-(3,5-dimethoxyphenyl)-N′-(1-methylethyl)-N-[3-(1-methyl-1H-pyrazol-4-yl)quinoxalin-6-yl]ethane-1,2-diamine

US Patent 11684620 · Granted Jun 27, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Synthetic options towards the manufacture of (6R,10S)-10-{4-[5-chloro-2-(4-chlor2025
Bi-heteroaryl substitute 1,4-benzodiazepines and uses thereof for the treatment 2023
Compounds2021
Pharmaceutical compositions comprising N-(3,5-dimethoxyphenyl)-N'-1 methylethyl)2021
Quinoxaline derivatives useful as FGFR kinase modulators2019
Process for the preparation of histamine H3 receptor modulators2019
Substituted 2-[3-(1-methyl-piperidin-4-yl)-propylamino]-pyrimidine-5-carboxylic 2018
Quinoxaline derivatives useful as FGFR kinase modulators2018
Process for the preparation of histamine H3 receptor modulators2017
Substituted 2-[3-(1-methyl-piperidin-4-yl)-propylamino]-pyrimidine-5-carboxylic 2017
Process for the preparation of histamine H3 receptor modulators2016
Benzoimidazol-2-yl pyrimidine derivatives2016